AI assistant
Sending…
TherapeuticsMD, Inc. — Director's Dealing 2014
May 14, 2014
35134_dirs_2014-05-14_2573c6ef-24fc-4b0a-80df-3bb63d66347a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2014-05-12
Reporting Person: Milligan John C.K. IV (Director, President/Secretary)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2014-05-12 | Common Stock | M | 20000 | $0.1018 | Acquired | 1742419 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-05-12 | Non-Qualified Stock Option (right to buy) | $0.1018 | M | 20000 | Disposed | 2019-01-01 | Common Stock (20000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3892187 | Indirect |
Footnotes
F1: All shares underlying this option vested on or before Janury 1, 2012.
More from TherapeuticsMD, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Major Shareholding Notification
2026
Apr 7
Annual Report
2026
Apr 1
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 30
Regulatory Filings
2026
Jan 20
Director's Dealing
2025
Dec 29
Regulatory Filings
2025
Dec 16